Tirzepatide's dual GIP+GLP-1 action produces dramatic results — and significant side effects during dose escalation. tr8ck tracks your injections, weight, sleep, mood, nutrition, and energy so you can navigate every dose step with data.
Mounjaro is a dual agonist: it activates both GIP receptors and GLP-1 receptors simultaneously. This dual mechanism produces faster and more significant weight loss than semaglutide alone — but also a more aggressive dose escalation schedule with more intense side effects during transitions.
Clinical trials showed 15–22% body weight loss over 72 weeks — significantly more than semaglutide. This rapid rate makes protein tracking critical. Without adequate protein and resistance training, a meaningful portion of that weight loss will be muscle, not fat.
Mounjaro escalates from 2.5mg to 15mg across 6 dose levels (2.5 → 5 → 7.5 → 10 → 12.5 → 15mg). Each transition can bring a fresh wave of side effects. Knowing which dose level caused the most disruption to your energy and sleep is valuable clinical data.
Unlike starting a new medication once, Mounjaro users go through an adjustment period at every dose escalation step. Tracking energy, mood, and appetite at each step shows you your personal pattern and helps you plan — some people tolerate certain dose jumps much better than others.
Many Mounjaro users with obesity-related sleep issues see dramatic sleep improvement over 6–12 months. Without baseline sleep data from day one, you can't quantify or appreciate this improvement. Starting your sleep log on injection day one creates the full before/after picture.
Six dose levels, each with a 4-week adjustment period. tr8ck's medication module logs each injection and correlates your wellbeing data at every step.
Body adjustment period. Side effects typically mild. Appetite suppression often noticeable from week 1–2. Begin logging all health metrics from day one.
Nausea commonly increases at this transition. First meaningful weight loss results typically visible. Energy may dip briefly in weeks 5–6.
Significant appetite suppression for most users. Protein tracking becomes critical here to prevent muscle loss as calorie deficit deepens.
Weight loss accelerating. Sleep quality often begins improving noticeably at this stage for users with obesity-related sleep disruption.
Near-maximum dose. Some users stay at this level long-term. Mood scores typically at their best by this stage in the journey.
Maximum approved dose. SURMOUNT-1 showed 22% average body weight loss at this level over 72 weeks. Continue tracking for the full health picture.
Tirzepatide's appetite suppression works indiscriminately. It reduces total calorie intake without ensuring you get adequate protein. When you're eating 1,200–1,400 calories and not tracking macros, you may be getting only 50–60g of protein per day — far below the 100–150g needed to preserve muscle mass during rapid weight loss.
Muscle loss matters beyond aesthetics. Muscle is metabolically active tissue. Losing muscle reduces your resting metabolic rate — making it harder to maintain weight loss if tirzepatide is ever discontinued, and accelerating the weight regain that statistics show affects most GLP-1 users after stopping.
tr8ck's nutrition module makes protein tracking effortless. Log what you eat, watch your daily protein total, and tr8ck correlates protein intake with energy levels and weight loss rate over time.
Track daily protein (target: 0.7–1g per lb goal body weight)
Log resistance training sessions 2–3x per week minimum
Monitor weekly weight loss rate — faster than 1–1.5% body weight/week may indicate muscle loss
Track energy levels — persistent fatigue may signal inadequate protein or calories
Correlate protein intake with how you feel — tr8ck's AI surfaces this connection automatically
Every module matters for tirzepatide users. Medication logging, nutrition, sleep, mood, exercise, and AI insights — all connected in one free app.
Quitting smoking is a goal you can track in tr8ck, not a separate module.
The best Mounjaro app tracks injections plus the full health picture tirzepatide affects. tr8ck correlates your dose history with sleep quality, mood, energy, protein intake, and weight trend — showing you at which dose transitions side effects peaked and whether nutrition strategies actually reduce nausea.
SURMOUNT-1 trial data showed 15–22% average body weight loss over 72 weeks depending on dose, with the 15mg dose producing the most significant results. This is faster than semaglutide. Individual results vary significantly. Weekly weight tracking in tr8ck from day one shows your personal rate clearly.
Track nausea and GI discomfort (worst weeks 1–3 at each new dose), fatigue and energy dips, appetite changes, and sleep quality. In tr8ck, daily mood and energy scores automatically correlate with your injection and dose history to show your personal side effect pattern at each level.
Two essentials: adequate protein (0.7–1g per lb of goal body weight daily) and resistance training 2–3x per week. With appetite suppressed, hitting protein targets requires intentional tracking. tr8ck's nutrition module makes this easy and tr8ck correlates protein intake with energy levels so you can see the effect directly.
Typically biphasic: some disruption during dose escalation (nausea, GI discomfort), followed by improvement over 6–12 months as weight decreases. Users with obesity-related sleep issues often see dramatic improvement. Starting your sleep log on day one creates the full before/after record — data that is genuinely motivating.
Free to start. Injection log, protein tracking, sleep, mood, weight trend, and AI insights — all connected in tr8ck.
Try tr8ck FreeAlso worth reading